Controlled Substance Inventory Management in Pharmacies
A comprehensive guide to conducting, documenting, and maintaining accurate controlled substance inventories to ensure compliance and prevent diversion.
RELATED LINKS
For additional resources to support pharmacy controlled substance ordering and inventory compliance click HERE.
FULL ARTICLE
Maintaining an accurate and complete inventory of controlled substances is essential for pharmacy compliance, operational integrity, and diversion prevention. Effective inventory management helps identify discrepancies early, supports regulatory inspections, and ensures accountability across all pharmacy operations.
This guide outlines how pharmacies should conduct inventories, when inventories are required, and how to manage ongoing tracking of controlled substances.
Staff Responsibilities & Accountability
Inventory management is a shared responsibility across the pharmacy team.
- All staff must support accurate inventory practices
- Discrepancies must be reported immediately
- Ongoing training ensures proper handling and documentation of controlled substances
The pharmacist-in-charge typically oversees inventory completion, recordkeeping, and compliance.
What Defines a Controlled Substance Inventory
An inventory is a complete physical count and documented record of all controlled substances under the pharmacy’s control.
This includes:
- Active stock inventory
- Unsaleable or quarantined medications (e.g., expired, damaged, recalled)
- Items designated for reverse distribution or wholesaler return
- Prescriptions prepared and awaiting pickup (will-call inventory)
Inventories must be maintained in written or electronic form at the registered pharmacy location.
Required Inventory Elements
Each inventory record must include:
- Date of inventory
- Whether taken at the start or end of business
- Drug name, strength, and dosage form
- Package size and number of containers
- Total quantity on hand
Counting Requirements
- Schedule II: Exact counts required
- Schedule III–V:
- Estimated counts allowed for containers under 1,000 units
- Exact counts required for larger containers
- Best practice: exact counts for all controlled substances
Additional required details include:
- Identification of unsaleable inventory
- Pharmacy name, address, and DEA number
- Signature of the individual completing the inventory
Record Organization
- Schedule II inventories must be separated from Schedule III–V
- Records must be readily retrievable
- Retention period: minimum of 2 years
- Inventories do not need to be routinely submitted to regulatory agencies but must be available upon request.
When Inventories Must Be Conducted
Controlled substance inventories are required in several key scenarios:
- Initial Inventory
- Completed upon receiving a DEA registration
- “Zero inventory” must be documented if no stock is present
- Biennial Inventory
- Conducted at least every two years
- New or Rescheduled Drugs
- Inventory required when a substance is newly scheduled or reclassified
- Change in Pharmacist-in-Charge
- Inventory performed within a defined timeframe after transition
- Pharmacy Closure or Transfer
- State-Specific Requirements
- As Needed (Event-Driven)
- Theft, loss, or suspected diversion
- Fire, natural disaster, or other incidents
Perpetual Inventory for Schedule II Substances
Schedule II drugs typically require ongoing tracking through a perpetual inventory system.
Methods Include:
- Physical Logbook
- Organized binder (often A–Z by drug/NDC)
- Separate inventory sheet per drug
- Stored in an accessible location
- Electronic Systems
- Digital tracking within pharmacy software
- Must capture the same data as manual logs
Tracked Activities Include:
- Quantities received
- Prescriptions dispensed
- Returns to stock
- Transfers in/out
- Returns to wholesalers or reverse distributors
- Adjustments (overages/shortages)
- Counts and reconciliations
All entries should be recorded in real time or as close to the activity as possible.
Physical Counts & Reconciliation
- Periodic physical counts must be completed per state requirements
- Results should be documented within the perpetual inventory system
- Any discrepancies must be:
- Reported immediately
- Investigated thoroughly
- Documented and resolved
Inventory for Schedule III–V Substances
- Physical inventories must be conducted per state requirements
- Documentation must follow the same general standards as Schedule II
- Discrepancies must be promptly investigated and documented
Pharmacy System Inventory Management
In addition to manual or perpetual logs, pharmacies often maintain inventory within a pharmacy management system.
Best Practices:
- Maintain accurate “balance on hand” quantities
- Restrict system permissions for adjusting controlled substance counts
- Use system adjustment features rather than manual overrides whenever possible
If Manual Adjustments Are Required:
- Only authorized personnel (typically a pharmacist) should perform them
- Each adjustment must include:
- Date and time
- Quantity change
- Reason for adjustment
- Documentation (e.g., invoice or order reference)
- Staff identification (initials or name)
All adjustments and discrepancies must be documented and reviewed to ensure compliance.
Maintaining a structured and accurate controlled substance inventory system is essential for preventing diversion, ensuring regulatory compliance, and supporting safe pharmacy operations. By combining routine inventories, perpetual tracking, and strong documentation practices, pharmacies can remain audit-ready and operationally secure.
Disclaimer: These tools and templates are intended for general informational purposes and are provided by Montana Family Pharmacies as a service to pharmacies. While we try to keep the information timely and accurate, we make no guarantees. These tools and templates are not a substitute for legal, regulatory, or professional advice.
Policies and procedure, templates, checklists, and other tools should be customized to fit the specific needs and regulatory requirements of your pharmacy.
Montana Family Pharmacies disclaims any liability for any damages, losses, or other consequences arising from the use or reliance on the tools or policy templates.